Literature DB >> 7509259

Effects of a nitric oxide synthase inhibitor in humans with septic shock.

A Petros1, G Lamb, A Leone, S Moncada, D Bennett, P Vallance.   

Abstract

OBJECTIVE: Studies in animals have indicated that increased production of nitric oxide from an inducible isoform of nitric oxide synthase contributes to the pathophysiology of endotoxic and cytokine induced shock. The aim of this study was to determine the role of nitric oxide in septic shock in humans.
METHODS: The study was a randomised, double blind, placebo controlled investigation of the effects of the nitric oxide synthase inhibitor NG monomethyl-L-arginine (L-NMMA) in 12 patients with severe sepsis associated with hypotension. Measurements of haemodynamic, haematological, and biochemical variables were made.
RESULTS: L-NMMA (0.3 and 1 mg.kg-1) produced a dose dependent increase in mean arterial pressure, systemic vascular resistance, pulmonary vascular resistance, central venous pressure, and pulmonary artery occlusion pressure, and a decrease in cardiac output and heart rate. In response to the highest dose of L-NMMA systemic vascular resistance increased from 547(SEM 92) to 889(143) dyne.s.cm-5, mean arterial blood pressure increased from 80.9(2.9) to 100.5(6.1) mm Hg, and cardiac output decreased from 11.2(2.1) to 8.9(1.9) litres.min-1. Continuous infusion of L-NMMA (1 mg.kg-1 x h-1) produced sustained haemodynamic changes. Platelet numbers decreased during the course of the study in both the L-NMMA and the placebo group and did not differ significantly between the groups.
CONCLUSIONS: Low doses of L-NMMA cause a widespread increase in vascular tone and raise blood pressure in patients with septic shock. Overproduction of nitric oxide appears to be an important mechanism in septic shock in patients, and inhibition of nitric oxide synthesis might provide a novel therapeutic approach to this condition. However, L-NMMA produced a fall in cardiac output and it is possible that this would worsen tissue perfusion. Larger studies examining the effects of L-NMMA on mortality and morbidity are now required.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509259     DOI: 10.1093/cvr/28.1.34

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  65 in total

1.  Activation of the L-arginine nitric oxide pathway in severe sepsis.

Authors:  T Duke; M South; A Stewart
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

2.  Effects of hypothermia on mortality and inflammatory responses to endotoxin-induced shock in rats.

Authors:  Takumi Taniguchi; Hiroko Kanakura; Yasuhiro Takemoto; Ken Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

3.  The in Vitro Immune-Modulating Properties of a Sweat Gland-Derived Antimicrobial Peptide Dermcidin.

Authors:  Echo Wang; Xiaoling Qiang; Jianhua Li; Shu Zhu; Ping Wang
Journal:  Shock       Date:  2016-01       Impact factor: 3.454

Review 4.  Differential signaling in presynaptic neurotransmitter release.

Authors:  Wim E J M Ghijsen; A G Miriam Leenders
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

Review 5.  Hydrogen sulfide: a gasotransmitter of clinical relevance.

Authors:  M Scott Vandiver; Solomon H Snyder
Journal:  J Mol Med (Berl)       Date:  2012-03       Impact factor: 4.599

6.  Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock.

Authors:  J A Avontuur; T C Stam; M Jongen-Lavrencic; J G van Amsterdam; A M Eggermont; H A Bruining
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

7.  Intensive insulin therapy protects the endothelium of critically ill patients.

Authors:  Lies Langouche; Ilse Vanhorebeek; Dirk Vlasselaers; Sarah Vander Perre; Pieter J Wouters; Kristin Skogstrand; Troels K Hansen; Greet Van den Berghe
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

9.  Bacterial clearance in septic mice is modulated by MCP-1/CCL2 and nitric oxide.

Authors:  Rachel N Gomes; Mariana G A Teixeira-Cunha; Rodrigo T Figueiredo; Patricia E Almeida; Silvio C Alves; Patrícia T Bozza; Fernando A Bozza; Marcelo T Bozza; Guy A Zimmerman; Hugo C Castro-Faria-Neto
Journal:  Shock       Date:  2013-01       Impact factor: 3.454

10.  A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy.

Authors:  Rachel Erin Graham; Michaela Cartner; James Winearls
Journal:  BMJ Case Rep       Date:  2015-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.